Programa científico del 12 International Forum on Mood and Anxiety Disorders
1. 12 th INTERNATIONAL FORUM
ON MOOD
AND ANXIETY DISORDERS
BARCELONA, 07-09 NOVEMBER, 2012
M.C. Escher “The Knot”
www.ifmad.org
CHAIRMAN: Siegfried KASPER (Austria)
CO-CHAIRMAN: Stuart A. MONTGOMERY (United Kingdom)
Preliminary Programme
2. DATES TO REMEMBER
16 September 2012
DEADLINE FOR SUBMISSION
OF ABSTRACT
16 September 2012
DEADLINE FOR REDUCED
REGISTRATION FEE
IMPORTANT ADDRESSES
Organizing Secretariat
74, Bd d’Italie - 98000 Monte-Carlo - Monaco
Ph. +377 97973555 - Fax +377 97973550
E-mail: ifmad@publicreations.com
Website: www.ifmad.org
Congress Venue
Hotel Rey Juan Carlos I
Avenida Diagonal, 661-671
08028 Barcelona
Spain
3. CONTENTS
Dates to Remember 2
Scientific Committee 4
Welcome Letter 5
Programme Overview 6
Preliminary Scientific Programme 7
Scientific Information 12
Registration 14
Hotel Accommodation and Payment 15
Congress venue / General Information 16
Registration Form 17
Hotel Accommodation Form 18
Forms available on internet:
www.ifmad.org
4. SCIENTIFIC COMMITTEE
Chairman
Siegfried Kasper (Austria)
Co-Chairman
Stuart A. Montgomery (United Kingdom)
Scientific Advisers
C. Allgulander (Sweden), C.A. Altamura (Italy),
C. Arango (Spain), D. Baldwin (United Kingdom), B. Bandelow (Germany),
M. Bauer (Germany), P. Blier (Canada),
G. Burrows (Australia), G.B. Cassano (Italy), K. Demyttenaere (Belgium),
J. Den Boer (The Netherlands), T. Dinan (Ireland), E. Eriksson (Sweden),
N. Fineberg (United Kingdom), S.H. Kennedy (Canada),
D. Lecic Tosevski (Serbia), M. Maj (Italy), A.A. Mathé (Sweden),
J. Mendlewicz (Belgium), H.J. Möller (Germany), S. Pallanti (Italy),
G. Papadimitriou (Greece), G. Papakostas (USA), Z. Rihmer (Hungary),
T. Roth (USA), A.F. Schatzberg (USA), A. Serretti (Italy),
D.J. Stein (South Africa), E. Vieta (Spain), L. Von Knorring (Sweden),
D. Winkler (Austria), S. Yamawaki (Japan), A. Young (United Kingdom),
J. Zohar (Israel)
4
5. WELCOME LETTER
To all prospective delegates.
The International Forum on Mood and Anxiety Disorders (IFMAD)
will be held from 07 to 09 November 2012 in Barcelona, Spain.
The most useful feature about IFMAD meetings is that current clinical
hot topics and new data are presented in a balanced format, adequately
dissected and discussed in a collegiate atmosphere, and digested over
dinner.
The meetings are always enjoyable and informative and along with
the usual updates on new treatments in other areas this year’s IFMAD
will be an efficient way of catching up with the latest developments.
This year topics that will be addressed include educational strategies to
prevent suicide, the place of antidepressants in bipolar depression, new
approaches in treating alcohol abuse, improving placebo control groups
and a core focus will be on the new antidepressants on the horizon.
We invite you to join us again in November 2012 to give you the
opportunity to keep abreast of the latest advances.
It will be our pleasure to welcome you in Barcelona.
Siegfried Kasper, Stuart A. Montgomery,
Chairman Co-Chairman
5
6. PROGRAMME OVERVIEW
Wednesday, Thursday, Friday,
November 07 November 08 November 09
09.00/10.30 09.00/10.30
Broad-spectrum symptom Cognitive dysfunction of
control in bipolar disorder - depression – a symptom
what are the challenges? that we fail to treat?
10.30/11.00 10.30/11.00
Coffee break Coffee break
11.00/12.30 11.00/12.30
Developments in
Hot topics
the treatment of Anxiety
in Mood disorders Disorders
12.30/13.30 12.30/13.30
Lunch Lunch
13.30/15.00 13.30/15.00
Optimizing treatment
New targets
outcomes in depression
and anxiety disorders for depression
14.30/16.00 15.00/16.00 15.00/16.00
Progress in Bipolar Debate: Poetry and the Measurement
Disorder Antidepressant of Depression -
response is clearcut a personal journey
16.00/16.30 16.00/16.30
Coffee break Coffee break
16.30/18.00
16.30/18.00 Negative, cognitive
Advances in treatment and depressive symptoms
of resistant depression
in schizophrenia
18.00/19.00
Opening Ceremony
NB: This agenda is subject to change
6
7. PRELIMINARY SCIENTIFIC PROGRAMME
WEDNESDAY, 07 November 2012
14.30-16.00 SO 01 PROGRESS IN BIPOLAR DISORDER
14.30-14.55 SO 0101 Treatment of mixed states
Eduard VIETA (Spain)
14.55-15.20 SO 0102 Treatment of bipolar depression
Alan YOUNG (United Kingdom)
15.20-15.45 SO 0103 Observational vs Randomised controlled studies
Rico NIL (Switzerland)
15.45-16.00 Discussion
16.00-16.30 Coffee break
16.30-18.00 SO 02 ADVANCES IN TREATMENT
OF RESISTANT DEPRESSION
16.30-16.55 SO 0201 Should we stop raising the dose
in nonresponders
Rasmus LICHT (Denmark)
16.55-17.20 SO 0202 Are two antidepressants better than one?
Michael BAUER (Germany)
17.20-17.45 SO 0203 Pharamacogentiecs in practice: are we close?
Alessandro SERRETTI (Italy)
17.45-18.00 Discussion
18.00-19.00 Opening Ceremony
7
8. PRELIMINARY SCIENTIFIC PROGRAMME
THURSDAY, 08 November 2012
09.00-10.30 SO 03 BROAD-SPECTRUM SYMPTOM
CONTROL IN BIPOLAR DISORDER -
WHAT ARE THE CHALLENGES?
Symposium sponsored by an unrestricted
educational grant from H. Lundbeck A/S
10.30-11.00 Coffee break
11.00-12.30 SO 04 HOT TOPICS IN MOOD DISORDERS
11.00-11.25 SO 0401 Making sense in making guidelines
Karl BROICH (Germany)
11.25-11.50 SO 0402 Educational strategies for preventing suicide:
review of studies in Slovenia, Gotland and Germany
Saska ROSKAR (Slovenia)
11.50-12.15 SO 0403 Why do celebrities die young?
Borwin BANDELOW (Germany)
12.15-12.30 Discussion
12.30-13.30 Lunch
8
9. PRELIMINARY SCIENTIFIC PROGRAMME
13.30-15.00 SO 05 OPTIMIZING TREATMENT OUTCOMES
IN DEPRESSION AND ANXIETY DISORDERS
Symposium sponsored by an unrestricted
educational grant from H. Lundbeck A/S
15.00-16.00 SO 06 DEBATE:
ANTIDEPRESSANT RESPONSE IS CLEARCUT
Pro: Elias ERIKSSON (Sweden)
Contra: Corrado BARBUI (Italy)
16.00-16.30 Coffee break
16.30-18.00 SO 07 NEGATIVE, COGNITIVE AND
DEPRESSIVE SYMPTOMS IN SCHIZOPHRENIA
16.30-16.55 SO 0701 Depressive and negative symptoms -
are they really separate?
Hans-Juergen MOELLER (Germany)
16.55-17.20 SO 0702 New treatments for cognitive symptoms
in schizophrenia
Raimund BULLER (France)
17.20-17.45 SO 0703 Treatment of affective or negative symptoms
of schizophrenia
Stefan LEUCHT (Germany)
17.45-18.00 Discussion
9
10. PRELIMINARY SCIENTIFIC PROGRAMME
FRIDAY, 09 November 2012
09.00-10.30 SO 08 COGNITIVE DYSFUNCTION
OF DEPRESSION - A SYMPTOM THAT
WE FAIL TO TREAT?
09.00-09.30 SO 0801 Current antidepressant treatments:
what do we have and what do we need?
Philip COWEN (United Kingdom)
09.30-10.00 SO 0802 Assessing cognitive dysfunction
in the depressed patient
Barbara SAHAKIAN (United Kingdom)
10.00-10.30 SO 0803 Review of current evidence for treatment
of cognitive dysfunction of depression
Siegfried KASPER (Austria)
Symposium sponsored by an unrestricted
educational grant from H. Lundbeck A/S
10.30-11.00 Coffee break
11.00-12.30 SO 09 DEVELOPMENTS IN THE TREATMENT
OF ANXIETY DISORDERS
11.00-11.25 SO 0901 Sexual Disorders and OCD
Jose MENCHON (Spain)
11.25-11.50 SO 0902 Is hoarding a separate disorder?
Stefano PALLANTI (Italy)
11.50-12.15 SO 0903 Long term treatment of anxiety disorders
and OCD
David BALDWIN (United Kingdom)
12.15-12.30 Discussion
12.30-13.30 Lunch
10
11. PRELIMINARY SCIENTIFIC PROGRAMME
13.30-15.00 SO 10 NEW TARGETS FOR DEPRESSION
13.30-13.55 SO 1001 Are there new potential targets for depression?
Torgny SVENSSON (Sweden)
13.55-14.20 SO 1002 Neuroinflammation in MDD: current status and
treatment options
Johan den BOER (The Netherlands)
14.20-14.45 SO 1003 Cardiovascular outcome in MDD
Timothy DINAN (Ireland)
14.45-15.00 Discussion
15.00-16.00 SO 11 POETRY AND THE MEASUREMENT
OF DEPRESSION - A PERSONAL JOURNEY
Siegfried KASPER (Austria)
Stuart MONTGOMERY (United Kingdom)
11